Marizyme, Inc. (MRZM) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
555 HERITAGE DRIVE JUPITER, FL 33458 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 511 | 4,072 | 2,903 | 0 | 0 | 29 | 52 | ||
| Cash and cash equivalents | 511 | 4,072 | 2,903 | 0 | 0 | 29 | 52 | ||
| Receivables | 88 | 9 | 41 | ||||||
| Inventory, net of allowances, customer advances and progress billings | 216 | 22 | 56 | ||||||
| Inventory | 216 | 22 | 56 | ||||||
| Prepaid expense | 1,126 | 257 | 106 | 20 | 17 | ||||
| Asset, held-for-sale, not part of disposal group | 120 | 131 | |||||||
| Other undisclosed current assets | 15 | 41 | 6 | 27 | |||||
| Total current assets: | 1,955 | 4,402 | 3,106 | 0 | 20 | 171 | 209 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 1,485 | 1,159 | 1,318 | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 13 | 13 | 7 | ||||||
| Intangible assets, net (including goodwill) | 34,866 | 60,057 | 42,278 | 28,613 | 28,600 | ||||
| Goodwill | 7,191 | 7,191 | |||||||
| Intangible assets, net (excluding goodwill) | 27,675 | 52,866 | 42,278 | 28,613 | 28,600 | ||||
| Other undisclosed noncurrent assets | 369 | 369 | 374 | 2,610 | 2,610 | ||||
| Total noncurrent assets: | 36,732 | 61,598 | 43,977 | 28,613 | 28,600 | 2,610 | 2,610 | ||
| TOTAL ASSETS: | 38,688 | 65,999 | 47,084 | 28,613 | 28,620 | 2,782 | 2,819 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 1,365 | 1,596 | 478 | 270 | 43 | 35 | |||
| Accounts payable | 35 | ||||||||
| Other undisclosed accounts payable and accrued liabilities | 1,365 | 1,596 | 478 | 270 | 43 | ||||
| Debt | 1,133 | 128 | |||||||
| Due to related parties | 1,133 | ||||||||
| Other undisclosed current liabilities | 423 | 277 | 243 | 628 | 653 | ||||
| Total current liabilities: | 2,922 | 3,134 | 721 | 270 | 43 | 663 | 653 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,377 | 1,075 | |||||||
| Long-term debt, excluding current maturities | 495 | ||||||||
| Liabilities, other than long-term debt | 5,885 | 2,485 | |||||||
| Operating lease, liability | 1,062 | 882 | 1,075 | ✕ | ✕ | ✕ | |||
| Derivative instruments and hedges, liabilities | 4,824 | 2,485 | |||||||
| Other undisclosed noncurrent liabilities | 12,459 | 11,313 | (1,075) | ||||||
| Total noncurrent liabilities: | 18,344 | 15,175 | 1,075 | ||||||
| Total liabilities: | 21,266 | 18,309 | 1,796 | 270 | 43 | 663 | 653 | ||
| Equity | |||||||||
| Equity, attributable to parent, including: | 17,422 | 47,690 | 45,288 | 28,343 | 28,577 | 2,119 | 2,167 | ||
| Common stock | 41 | 41 | 36 | 20 | 20 | 32 | 32 | ||
| Treasury stock, value | (16) | (16) | (16) | (16) | |||||
| Additional paid in capital | 103,371 | 95,473 | 82,077 | 59,278 | 58,455 | 29,763 | 29,763 | ||
| Accumulated other comprehensive loss | (48) | (571) | |||||||
| Accumulated deficit | (85,989) | (47,824) | (36,826) | (30,981) | (29,923) | (27,653) | (27,083) | ||
| Other additional capital | 41 | 41 | 41 | 41 | |||||
| Other undisclosed equity, attributable to parent | 0 | ||||||||
| Total equity: | 17,422 | 47,690 | 45,288 | 28,343 | 28,577 | 2,119 | 2,167 | ||
| TOTAL LIABILITIES AND EQUITY: | 38,688 | 65,999 | 47,084 | 28,613 | 28,620 | 2,782 | 2,819 | ||
Income Statement (P&L) ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 233 | 210 | 197 | 20 | 101 | |||
| Other income | 68 | |||||||
| Cost of revenue | (54) | (20) | ||||||
| Other undisclosed gross profit | (87) | |||||||
| Gross profit: | 179 | 210 | 197 | 0 | 14 | |||
| Operating expenses | (37,503) | (9,032) | (5,997) | (1,058) | (247) | (139) | ||
| Other operating expense, net | (446) | |||||||
| Other expenses | (514) | |||||||
| Other undisclosed operating income | 446 | |||||||
| Operating loss: | (37,324) | (8,821) | (5,800) | (1,058) | (247) | (125) | ||
| Nonoperating expense | (842) | (2,177) | (45) | (2) | ||||
| Other nonoperating income (expense) | 3 | (2) | ||||||
| Interest and debt expense | 338 | (664) | (45) | (30) | ||||
| Loss from continuing operations: | (37,828) | (11,661) | (5,891) | (1,088) | (249) | (125) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (11,661) | (5,891) | (1,088) | (249) | (125) | ||
| Other undisclosed net income | 664 | 45 | 30 | |||||
| Net loss: | (37,828) | (10,998) | (5,845) | (1,058) | (249) | (125) | ||
| Other undisclosed net loss attributable to parent | (338) | (446) | ||||||
| Net loss available to common stockholders, diluted: | (38,166) | (10,998) | (5,845) | (1,058) | (249) | (571) | ||
Comprehensive Income ($ in thousands)
| 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 3/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (37,828) | (10,998) | (5,845) | (1,058) | (249) | (125) | ||
| Comprehensive loss, net of tax, attributable to parent: | (37,828) | (10,998) | (5,845) | (1,058) | (249) | (125) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.